Intelligence / Healthtech / PMA Approvals / Endospan , LTD.
Approvalsdevice change approved (PMA)21 Sept 2026
Endospan , LTD.
21 Sept 2026: Device change approved (PMA) · NEXUS Aortic Arch Stent Graft System. Recorded in the openFDA device PMA data.
- Decided
- 21 Sept 2026
- Device
- NEXUS Aortic Arch Stent Graft System
- Specialty
- Cardiovascular
- Type
- Supplement (Normal 180 Day Track)
- Reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Reference
- P250033 S004
- Location
- Alta, WY
What this signal means
A PMA approval is a high-risk device launch: reimbursement, distribution, clinical training and sales hires follow.
- Cardiovascular leads with 53 of 120, then Pathology (15).
- 35 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at Endospan , LTD.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
More in Cardiovascular
PMA Approvals
6 NovAbbott Vascular (Idef Technologies INC)device change approved (PMA) · Supera Peripheral Stent SystemApprovals6 NovMedalliance, LLCdevice change approved (PMA) · SELUTION SLR 014 PTCA Drug-Eluting BalloonApprovals5 NovAbbott Medicaldevice change approved (PMA) · UltiSynq Defibrillation lead; SurGrip Suture Sleeve AccessoryApprovals4 NovContego Medical, INC.device change approved (PMA) · Neuroguard IEP® 3-in-1 Carotid Stent, Post-Dilation Balloon System with Integrated Embolic ProtectionApprovals4 NovMedtronic Cardiac Rhythm Disease Managementdevice change approved (PMA) · Cobalt MRI CRT-D (DTPB2D1, DTPB2D4, DTPB2Q1, DTPB2QQ); Cobalt XT MRI CRT-D (DTPA2D1, DTPA2D4, DTPA2Q1, DTPA2QQ); Crome MApprovals4 NovMedtronic Cardiac Rhythm Disease Managementdevice change approved (PMA) · Cobalt MRI ICD (DDPB3D1, DDPB3D4, DVPB3D1, DVPB3D4); Cobalt XT MRI ICD (DDPA2D1, DDPA2D4, DVPA2D1, DVPA2D4); Crome MRI IApprovals
Source: openFDA device PMA data, data to 18 Nov 2026. Class III devices approved by FDA: original approvals and supplements that change the device (180-day, panel-track and special tracks). 30-day manufacturing notices are left out. AOS shows what the public record says; it does not verify or endorse the company.